Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 14/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 8/20 | 0.45 |
| ▸ | PDE4A | P27815 | 13/20 | 0.44 |
| ▸ | PDE4B | Q07343 | 13/20 | 0.44 |
| ▸ | PDE4C | Q08493 | 13/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 13/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | PNP | P00491 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667794 | 0.88 | PDE4A (0.49) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL9960806 | 0.87 | PNP (0.38) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL6272726 | 0.85 | PDE4A (0.49) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL1767742 | 0.84 | ADORA2A (0.39) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL8522266 | 0.84 | ADORA2B (0.51) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL5503490 | 0.84 | ADORA2A (0.49) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL8536000 | 0.83 | ADORA2B (0.53) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL6272293 | 0.83 | ADORA2B (0.53) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL4384737 | 0.83 | ADORA2B (0.53) | ADORA2AADORA2BPDE4APDE4BPDE4C | |
| SCHEMBL6265333 | 0.82 | PDE4A (0.46) | ADORA2AADORA2BPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725474-B2 | Modified nucleic acid | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-08-08 | — | — | US | claimed |
| EP-1419247-A2 | METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS | Direvo Biotech AG (DE) | 2004-05-19 | — | — | EP | claimed |
| WO-2003012100-A2 | METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS | DIREVO BIOTECH AG (DE) | 2003-02-13 | — | — | WO | claimed |
| EP-4658753-A1 | CHLORELLA MICROALGAE | Algenuity BV (NL) | 2025-12-10 | — | — | EP | disclosed |
| EP-4658093-A1 | FOOD COMPOSITION COMPRISING CHLOROPHYLL-DEFICIENT CHLORELLA BIOMASS WITH HIGH PROTEIN CONTENT >50WT% | Unilever IP Holdings B.V. (NL) | 2025-12-10 | — | — | EP | disclosed |
| EP-4658084-A1 | FOOD COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-12-10 | — | — | EP | disclosed |
| EP-4658754-A1 | ALGAE BIOMASS | Algenuity BV (NL) | 2025-12-10 | — | — | EP | disclosed |
| WO-2025082420-A1 | AQUEOUS EMULSION, METHOD FOR PREPARING THE SAME, COATING COMPOSITION AND ARTICLE | GUANGDONG HUARUN PAINTS CO., LTD. (CN) | 2025-04-24 | — | — | WO | disclosed |
| US-20250027033-A1 | MODIFIED STRAINS OF CHLORELLA VULGARIS AND METHOD OF PRODUCTION | ALGENUITY HOLDINGS LTD (GB) | 2025-01-23 | — | — | US | disclosed |
| WO-2024160737-A1 | FOOD COMPOSITION COMPRISING CHLOROPHYLL-DEFICIENT CHLORELLA BIOMASS WITH HIGH PROTEIN CONTENT >50WT% | UNILEVER IP HOLDINGS B.V. (NL) | 2024-08-08 | — | — | WO | disclosed |
| WO-2024160738-A1 | FOOD COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-08-08 | — | — | WO | disclosed |
| WO-2002004621-A2 | METHODS OF CREATING CONSTRUCTS USEFUL FOR INTRODUCING SEQUENCES INTO EMBRYONIC STEM CELLS | DELTAGEN, INC. (US) | 2002-01-17 | — | — | WO | disclosed |
| WO-2001092308-A2 | CYSTINE-KNOT POLYPEPTIDES: CLOAKED-2 MOLECULES AND USES THEREOF | AMGEN, INC. (US) | 2001-12-06 | — | — | WO | disclosed |
| US-6303618-B1 | ADMINISTERING PURINE COMPOUND WHICH INHIBITS CYCLIC DEPENDENT KINASE ACTIVITY FOR THERAPY OF TUMOR OR OTHER CELL PROLIFERATION DISORDER | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 2001-10-16 | — | — | US | disclosed |
| EP-1127165-A1 | METHOD AND TEST KIT FOR ANALYZING DNS REPAIR | Nehls, Peter (DE) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000026402-A1 | METHOD AND TEST KIT FOR ANALYZING DNS REPAIR | NEHLS PETER (DE) | 2000-05-11 | — | — | WO | disclosed |
| WO-2000017220-A1 | ANTISENSE MODULATION OF FAN EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-1999002162-A9 | CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES | CANCER RES CAMPAIGN TECH (GB) | 1999-07-29 | — | — | WO | disclosed |
| EP-0846772-A1 | Multifunctional ligand system for cell-specific transfer of nucleic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-10 | — | — | EP | disclosed |
| EP-0702683-A1 | 06-SUBSTITUTED GUANINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE IN TREATING TUMOUR CELLS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-03-27 | — | — | EP | disclosed |